09:43 AM EST - Bausch Health Companies Inc. : And its gastroenterology business, Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced the recipients of the inaugural Salix Gastrointestinal Health Scholars Program. Ten outstanding students living with GI disease who are pursuing their higher education goals will each receive a $10,000 scholarship award. Bausch Health Companies Inc.
shares T.BHC are trading unchanged at $23.22.
